SVSuresh Vaikkakara

Suresh Vaikkakara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Suresh Vaikkakara has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Alok Sachan

    A Department of Endocrinology and Metabolism , Sri Venkateswara Institute of Medical Sciences , Tirupati , India

    5 shared publications
  • Arun Mukka

    Department of Endocrinology, Yashoda Hospitals, Hyderabad, Telangana, India

    4 shared publications
  • Alladi Mohan

    Department of Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India

    2 shared publications
  • Ashok Venkatanarasu

    A Department of Endocrinology and Metabolism , Sri Venkateswara Institute of Medical Sciences , Tirupati , India

    2 shared publications
  • Sailaja Anantarapu

    Department of Endocrinology, Tirupati, India

    2 shared publications
  • Sunil Epuri

    Department of Endocrinology, Tirupati, India

    2 shared publications

Latest Publications

  • Open Access

    Intelectin-1 (ITLN1) Val109Asp (rs2274907) polymorphism: Association with circulating Omentin-1 Levels and Metaflammation in Men with Type 2 Diabetes

    by Saidaiah Ikkurthi, Srinivasan Raghavan Abu, Suresh Vaikkakara, Jayanthi Rajendran, Desai Vidya Sripad, M.Rajeswari

    Aim Omentin-1 is an adipokine associated with insulin sensitivity and inflammatory processes, while the ITLN1 Val109Asp (rs2274907) variant has been implicated in metabolic phenotypes. We investigated its association with circulating omentin-1 and a metaflammatory phenotype in men with type 2 diabetes mellitus (T2DM). Methods In this cross-sectional study, 225 men with T2DM were genotyped for ITLN1 Val109Asp (TT, AT, and AA). Anthropometric, glycaemic, insulin-resistance, lipid, inflammatory, and haematological parameters were compared across genotypes. Associations between circulating omentin-1 and metabolic, inflammatory, and haematological parameters were assessed using Spearman correlation. Logistic regression evaluated associations between the variant and obesity under dominant, recessive, and additive models. Receiver operating characteristic analysis assessed discrimination of low circulating omentin-1. Results Omentin-1 concentrations decreased progressively from TT to AT to AA genotypes [749.6, 627.9, and 483.2 ng/L, respectively; P < 0.001], whereas BMI, HOMA-IR, METS-IR, lipid abnormalities, and inflammatory markers showed less favourable profiles in the AA group. Genotype and allele distributions differed across BMI phenotypes (P = 0.027 and P = 0.002, respectively). Omentin-1 was inversely correlated with BMI, WHR, HOMA-IR, and METS-IR and positively correlated with QUICKI across genotype groups. Each additional A allele was associated with higher odds of obesity (age-adjusted OR 1.97, 95% CI 1.27–3.05; P = 0.002). IL-8 showed the highest discrimination for low omentin-1 (AUC 0.976, 95% CI 0.959–0.992). Conclusion ITLN1 Val109Asp was associated with circulating omentin-1 concentrations and a metaflammatory phenotype in men with T2DM, linking genetic variation with a metabolic–inflammatory profile.

  • Unanticipated intraoperative haemodynamic challenges during adrenalectomy for a phaeochromocytoma misdiagnosed as an adrenocortical tumour

    by Sripriya R, Priyanga Sivakumar, Rohini Dattatri, Thrylokya Sankar, Mallikarjun Gunjigavi, Suresh Vaikkakara

    A hypertensive woman in her mid-30s presented with flank pain probably secondary to a left adrenal mass. Biochemical evaluation, including serum cortisol, dehydroepiandrosterone and 24-hour urinary metanephrines, was negative, and the mass was diagnosed as a non-functioning adrenocortical tumour. Intraoperatively, tumour manipulation precipitated abrupt hypertensive surges with bradycardia, necessitating nitroglycerine and sodium nitroprusside infusion. Following adrenal vein ligation, profound hypotension ensued, requiring transient noradrenaline infusion to maintain adequate mean arterial pressure. Histopathology confirmed phaeochromocytoma, with positive synaptophysin and chromogranin A staining. This case underscores the potential for biochemically and clinically silent phaeochromocytomas and explores possible reasons for false-negative biochemical results. Intraoperative haemodynamic instability during adrenal manipulation should raise suspicion of catecholamine secretion, even in the absence of classical symptoms. The report emphasises the importance of invasive monitoring and anaesthetic preparedness to manage unexpected catecholamine release.

  • Open Access

    Mediators of energy homeostasis in hyperthyroidism

    by Avinash Patil, Suresh Vaikkakara, Mani Deepthi Dasari, Sandeep Ganta, Alok Sachan, Kiranmayi S. Vinapamula

    Objective: The aim of this study was to assess the effect of hyperthyroidism and its treatment on body weight and composition, insulin resistance, and mediators of appetite and energy homeostasis, namely ghrelin, leptin, adiponectin, and fibroblast growth factor 21 (FGF21). Subjects and methods: Thirty-five adult patients (27 female and 8 male, aged 39.63 ± 9.70 years) with overt hyperthyroidism were evaluated for leptin, ghrelin, adiponectin, and FGF21 levels; insulin resistance; and body composition using DEXA both at baseline and [...] ABSTRACT Objective: The aim of this study was to assess the effect of hyperthyroidism and its treatment on body weight and composition, insulin resistance, and mediators of appetite and energy homeostasis, namely ghrelin, leptin, adiponectin, and fibroblast growth factor 21 (FGF21). Subjects and methods: Thirty-five adult patients (27 female and 8 male, aged 39.63 ± 9.70 years) with overt hyperthyroidism were evaluated for leptin, ghrelin, adiponectin, and FGF21 levels; insulin resistance; and body composition using DEXA both at baseline and


  • Open Access

    Effect of Correction of Hyperthyroidism with Anti-thyroid Drugs on the Glycated Hemoglobin in Non-diabetic Patients with Primary Hyperthyroidism

    by Dasari Mani Deepthi, Suresh Vaikkakara, Avinash Patil, Sandeep Ganta, Alok Sachan, Katakam Raghavendra, Vinapamula S Kiranmayi, Amit Kumar Chowhan

    Background: Glycated hemoglobin (HbA1c) levels are dependent not only on the average blood glucose levels over the preceding 2 - 3 months but also on the turnover of erythrocytes. Hyperthyroidism is known to be associated with an increase in erythrocyte turnover that may falsely lower the HbA1c in relation to the level of glycemia. Objectives: To assess the impact of medical correction of hyperthyroidism on HbA1c, independent of changes in the fasting plasma glucose and 2-hour post-oral glucose tolerance test plasma glucose. Methods: Adult patients with overt hyperthyroidism (n = 36) were tested for their hemoglobin, reticulocyte percentage, HbA1c and fasting and post-oral glucose tolerance test (OGTT) 2-hour plasma glucose, both at baseline and following at least three months of near normalization of serum thyroxin on Carbimazole treatment. Results: Correction of hyperthyroidism in 36 patients was associated with an increase in the hemoglobin (P = 0.004) and a rise in HbA1c (P = 0.025), even though no significant change was observed in both the fasting (P = 0.28) and post OGTT two-hour plasma glucose (P = 0.54). Also, the proportion of patients with HbA1c ≥ 5.7% rose from 3/36 to 10/36; P = 0.016, while the proportion of patients with either abnormal fasting or abnormal post OGTT 2-hour plasma glucose or both did not show any significant change (P = 0.5). The sensitivity of HbA1c to diagnose prediabetes increased from 20% to 50% post- treatment. Conclusions: Glycated hemoglobin is falsely low in relation to glycemia in patients with untreated hyperthyroidism.


  • Open Access

    Assessment of functional outcome of patients undergoing surgery for chronic pancreatitis: A prospective study

    by Pagadala Naga Balaji Nitesh, Vutukuru Venkatarami Reddy, Sivarama Krishna Gavini, Suresh Vaikkakara, Chandramaliteeswaran Chandrahasan, Musunuru Bramheswara Rao, Dasari Varun

    This study was done with the aim of assessing impact of surgery for chronic pancreatitis on exocrine and endocrine functions, quality of life and pain relief of patients. 35 patients of chronic pancreatitis who underwent surgery were included. Exocrine function assessed with fecal fat globule estimation and endocrine function assessed with glycated haemoglobin (HbA1C), fasting plasma glucose (FPG), Insulin and C-peptide levels. Percentage (%) beta cell function by homeostatic model assessment (HOMA) was determined using web-based calculator. Quality of life (QOL) and pain assessment was done using Short form survey (SF-36) questionnaire and Izbicki scores respectively. Follow up done till 3 months following surgery. Endocrine insufficiency was noted in 13 (37%) patients in the postoperative period compared to 17 (49%) patients preoperatively (p=0.74). Exocrine insufficiency was detected in 11 (32%) patients postoperatively compared to 8 (23%) patients preoperatively, with denovo insufficiency noted in 3 (8%) patients (p<0.05). The mean Izbicki score at 3 months postoperatively was remarkably lower compared to preoperative score (29.3±14.3 vs. 60.6±12.06; p<0.05). QOL at 3 months following surgery for chronic pancreatitis was significantly better than preoperative QOL (50.24±22.16 vs. 69.48±20.81; p<0.05). Significant pain relief and improvement in quality of life among patients of chronic pancreatitis following surgery. However, worsening of exocrine function with only clinical improvement of endocrine function was also noted.


  • Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance

    by Shalini Patlolla, Suresh Vaikkakara, Alok Sachan, Ashok Venkatanarasu, Bharath Bachimanchi, Aparna Bitla, Sarala Settipalli, Sumathi Pathiputturu, Roopa Naik Sugali, Sravani Chiri

    Background: Insulin resistance and obesity are not universal features of polycystic ovary syndrome (PCOS). We planned to assess the differences between patients with nonobese /insulin-sensitive phenotype vs. obese/ insulin-resistant phenotype in terms of the potential mechanisms underlying their hyperandrogenism. Materials and methods: A total of 52 women satisfying Androgen Excess Society (AES) criteria were included. Hormonal and metabolic profile including prolactin, dehydroepiandrosterone sulfate (DHEAS), free testosterone, sex hormone binding globulin (SHBG), fasting plasma glucose and insulin were measured in follicular phase. Results: DHEAS was found to be higher in the nonobese patients as compared to the obese (p = 0.01). There was also a strong trend for a higher DHEAS among patients with lower insulin resistance by homeostatic model assessment (HOMA-IR< 2.3) (p = .06).While the total testosterone (p = .044) and SHBG (p = .007) were found to be lower in the more insulin-resistant group (HOMA-IR ≥ 2.3), the free testosterone levels were similar. However, the percentage of free testosterone was higher in the more insulin-resistant group (p = .005). Conclusions: The hyperandrogenic state in PCOS appears to have heterogenous origins. Nonobese patients with PCOS have adrenal hyperandrogenism as the underlying mechanism while their obese/ insulin-resistant counterparts have low SHBG and hence an increased fraction of free testosterone.


  • Open Access

    Impact of severity of illness on the function of the hypothalamo-pituitary-gonadal axis in postmenopausal women with acute severe illness: Implications for predicting disease outcome

    by Suresh Vaikkakara, Marella Neelima Raj, Alok Sachan, Alladi Mohan, Bhuma Vengamma, P. V. L. N. Srinivas Rao, Arun Mukka, Chiruvella Sravani, Amaresh P Reddy

    Background: While elevated levels of estradiol were predictive of mortality in critically ill surgical and trauma patients, their ability to predict outcome in nonsurgical patients has not been studied. We aimed to study the determinants of gonadotropin levels in acutely ill postmenopausal women with nonsurgical disease and the impact of changes in the gonadal axis on the outcome of these patients. Methods: Thirty-five postmenopausal women admitted to medical intensive care with acute severe illness and having a Simplified Acute Physiology Score (SAPS II score) ≥30 (in-hospital mortality rate ≥ 10%) were recruited. On the 5th day of hospitalization, fasting samples were collected at 8.00 am and tested for luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, free triiodothyronine, free thyroxine, thyrotropin, cortisol, prolactin, dehydroepiandrosterone, androstenedione, and sex hormone-binding globulin. Multiple linear regression analysis was performed to identify independent determinants if any of LH and FSH. Receiver operating characteristic (ROC) curves were drawn for different cutoffs of LH, FSH, and estradiol to diagnose mortality and prolonged hospitalization. Results: There was an independent negative association between the FSH and the SAPS II score (beta = −0.435; P = 0.014), but not with any of the other tested parameters (estradiol, prolactin, or cortisol). Among components of the SAPS II score, the total leukocyte count (TLC) was negatively associated with serum FSH (beta coefficient = −0.635, P = 0.013). None of these parameters were determinants of LH. On ROC analysis, neither estradiol nor gonadotropins were diagnostic for in-hospital mortality. However, among survivors, low estradiol was diagnostic for prolonged hospital stay (area under the curve = 0.785; P = 0.015). Conclusion: FSH, but not LH, is negatively associated with the severity of illness, particularly to its inflammatory component (TLC). Low estradiol in survivors was a predictor of prolonged hospital stay.


  • Open Access

    Correction of Hypothyroidism Leads to Change in Lean Body Mass without Altering Insulin Resistance

    by Sangeetha Sirigiri, Suresh Vaikkakara, Alok Sachan, P.V.L.N. Srinivasarao, Sunil Epuri, Sailaja Anantarapu, Arun Mukka, Srinivasa Rao Chokkapu, Ashok Venkatanarasu, Ravi Poojari

    Background: Hypothyroidism is associated with insulin resistance, dyslipidemia, and abnormal body composition. This study assessed changes in body composition and insulin resistance after thyroxine (T4) replacement in overt hypothyroidism. Methods: In this prospective longitudinal study carried out in a tertiary care center, adult nondiabetic patients with overt hypothyroidism were rendered euthyroid on T4. Anthropometry including skinfold thickness (SFT) at the triceps and subscapularis was recorded. Patients underwent testing for fasting plasma glucose, creatinine, serum insulin, T4, thyrotropin (TSH) and body composition analysis by dual-energy X-ray absorptiometry (DEXA) both before and at 2 months after restoration to the euthyroid state. Results: Twenty-seven patients (20 female and 7 male) aged 35.3 ± 11.0 years (min-max: 17-59 years) with overt hypothyroidism were recruited. Serum T4 at the time of recruitment was 48.9 ± 24.6 nmol/l (normal range = 64.4-142 nmol/l). All patients had TSH ≥50 µIU/l. Following treatment, there was a mean body weight reduction of 1.7 kg (p = 0.01). Waist circumference as well as triceps and subscapularis SFT decreased significantly (p < 0.001). There was no change in fat mass (FM), percentage of fat (%FM) or bone mineral content in any of the specified regions or in the body as a whole. In contrast, mean lean body mass (LBM) decreased significantly by 0.8 kg (p < 0.01) in the trunk and 1.3 kg (p < 0.01) in the whole body. Insulin resistance and level of glycemia were not affected by treatment with T4. Conclusion: LBM decreases significantly without affecting FM after correction of hypothyroidism. Insulin resistance was not influenced by T4 treatment.


  • Open Access

    Evaluation of activity of hypothalamo-pituitary-gonadal axis in postmenopausal women suffering from severe acute illness

    by V Suresh, M Neelima Raj, Arun Mukka, Amaresh Reddy, Alok Sachan, Alladi Mohan, B Vengamma, P.V.L.N. Srinivas Rao

    Background & objectives: Postmenopausal women constitute an ideal model for studying the extent of hypothalamo-pituitary gonadal (HPG) axis suppression in critical illness as the gonadotropins are normally high and non-cyclical in them. The objective was to assess the impact of acute severe illness in postmenopausal women on the HPG axis and the activities of the hypothalamo-pituitary-adrenal (HPA), the hypothalamo- pituitary-thyroid (HPT) axes; and levels of serum prolactin, by comparison between critically ill postmenopausal women and otherwise healthy postmenopausal women. Methods: Thirty five consecutive postmenopausal women older than 60 yr admitted to medical intensive care with a s0 implified a0 cute p0 hysiology s0 core II (SAPS II) more than 30 were included. On day five of their in-hospital stay, blood samples were collected for oestradiol, luteinizing hormone (LH), follicle stimulating hormone (FSH), cortisol, androstenedione, prolactin and thyroid profile. Thirty five apparently healthy postmenopausal women were selected as controls. Results: Levels of LH, FSH, thyrotropin, free thyroxin (fT 4 ) and free tri-iodothyronine (fT 3 ) were lower while oestradiol, cortisol and dehydroepiandrosterone were higher among patients in comparison to healthy controls. Prolactin levels were similar in patients and controls. Among sick patients both FSH and fT 4 showed a negative correlation ( P<0.05) with the SAPS II score. Interpretation & conclusions: In critically ill postmenopausal women, paradoxically elevated oestrogen levels despite gonadotropin suppression suggests a non-ovarian origin. Prolactin remained unaltered in patients despite their illness, possibly reflecting atrophy of lactotrophs in menopause.


  • Open Access

    Effects of thyroid hormone replacement on glycated hemoglobin levels in non diabetic subjects with overt hypothyroidism

    by Sailaja Anantarapu, Suresh Vaikkakara, Alok Sachan, Bobbidi Venkata Phaneendra, Mustur Manohar Suchitra, Amaresh Ponnala Reddy, Sunil Epuri, Arun Mukka, Dharaneswari Vemvakam

    Key words: Glycated hemoglobin; hypothyroidism; thyroxine